Dexamethasone induced hyperglycaemia and adverse outcomes – Are we there yet?

Dhatariya, Ketan K. (2022) Dexamethasone induced hyperglycaemia and adverse outcomes – Are we there yet? Medical Hypotheses, 164. ISSN 0306-9877

[thumbnail of 1-s2.0-S0306987722001190-main] PDF (1-s2.0-S0306987722001190-main) - Accepted Version
Restricted to Repository staff only until 22 May 2023.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Request a copy


Peri-operative hyperglycaemia is associated with poor post-operative outcomes in people with and without diabetes. Dexamethasone is a commonly used drug which works well to control post-operative nausea and vomiting. However, it is well recognised to cause transient hyperglycaemia. A 2018 Cochrane analysis and a recent large randomised controlled trial suggested that dexamethasone use was not associated with an increased risk of surgical site infection in those with or without diabetes. I argue that the data used to generate the Cochrane data were weak and of very low quality. My hypothesis is that the recent large study on dexamethasone use and surgical site infections did the wrong analysis, meaning that the safety of dexamethasone has yet to be established.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 24 May 2022 15:03
Last Modified: 23 Oct 2022 03:46
DOI: 10.1016/j.mehy.2022.110879

Actions (login required)

View Item View Item